Literature DB >> 1833342

Increased expression of Fc epsilon R2/CD23 on peripheral blood B lymphocytes and serum IgE levels in Kawasaki disease.

S Furukawa1, T Matsubara, T Motohashi, K Sasai, S Nakachi, Y Umezawa, K Yabuta.   

Abstract

We analyzed the expression of Fc epsilon R2/CD23 on the peripheral blood B lymphocytes of 10 patients with Kawasaki disease (KD) using a fluorescence-activated cell sorter. The absolute count of CD23-positive B lymphocytes and the ratio of CD23-positive B lymphocytes to B lymphocytes were high during the acute stage of KD in comparison to those during the convalescent stage and in control subjects. In addition, both the increased number of CD23-positive B lymphocytes and the increased serum IgE levels appeared during the latter part of the acute stage. These results suggest that the increased number of CD23-positive B lymphocytes during the latter part of the acute stage in KD reflect the activation of B lymphocytes and have an important role in IgE-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833342     DOI: 10.1159/000235446

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  11 in total

Review 1.  Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.

Authors:  T Matsubara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

2.  Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease.

Authors:  J C Burns; C Shimizu; H Shike; J W Newburger; R P Sundel; A L Baker; T Matsubara; Y Ishikawa; V A Brophy; S Cheng; M A Grow; L L Steiner; N Kono; R M Cantor
Journal:  Genes Immun       Date:  2005-08       Impact factor: 2.676

3.  CTLA-4, position 49 A/G polymorphism associated with coronary artery lesions in Kawasaki disease.

Authors:  Ho-Chang Kuo; Chi-Di Liang; Hong-Ren Yu; Chih-Lu Wang; I-Chun Lin; Chieh-An Liu; Jen-Chieh Chang; Chiu-Ping Lee; Wei-Chiao Chang; Kuender D Yang
Journal:  J Clin Immunol       Date:  2010-11-17       Impact factor: 8.317

4.  Soluble CD23 antigen in Kawasaki disease and other acute febrile illnesses.

Authors:  T Matsubara; S Furukawa; T Motohashi; K Okumura; K Yabuta
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

5.  Increased Risk of Kawasaki Disease in Infants Born of Mothers With Immune Disorders.

Authors:  Hsiao-Wen Chu; Chien-Heng Lin; Ming-Chih Lin; Ya-Chi Hsu
Journal:  Front Pediatr       Date:  2021-05-14       Impact factor: 3.418

6.  Antenatal Dexamethasone Exposure in Preterm Infants Is Associated with Allergic Diseases and the Mental Development Index in Children.

Authors:  Wan-Ning Tseng; Chih-Cheng Chen; Hong-Ren Yu; Li-Tung Huang; Ho-Chang Kuo
Journal:  Int J Environ Res Public Health       Date:  2016-12-03       Impact factor: 3.390

Review 7.  Kawasaki Disease: The Role of Immune Complexes Revisited.

Authors:  Stephanie Menikou; Paul R Langford; Michael Levin
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

8.  Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease.

Authors:  Kazuya Shirato; Yoshio Imada; Miyuki Kawase; Keiko Nakagaki; Shutoku Matsuyama; Fumihiro Taguchi
Journal:  J Med Virol       Date:  2014-04-24       Impact factor: 2.327

Review 9.  Kawasaki Disease and Allergic Diseases.

Authors:  Po-Yu Huang; Ying-Hsien Huang; Mindy Ming-Huey Guo; Ling-Sai Chang; Ho-Chang Kuo
Journal:  Front Pediatr       Date:  2021-01-07       Impact factor: 3.418

10.  Elevated Serum Levels of IL-21 in Kawasaki Disease.

Authors:  Yon Jung Bae; Mi Hyun Kim; Hae Yong Lee; Young Uh; Mee Kyung Namgoong; Byung Ho Cha; Jin-Kyong Chun
Journal:  Allergy Asthma Immunol Res       Date:  2012-06-29       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.